Literature DB >> 2989309

Antibody-capture ELISA for detection of immunoglobulin M antibodies in sera from Japanese encephalitis and dengue hemorrhagic fever patients.

K Bundo, A Igarashi.   

Abstract

Immunoglobulin M (IgM) antibody titers in paired sera from 19 encephalitis and 44 dengue hemorrhagic fever (DHF) patients in Thailand and 42 Japanese encephalitis (JE) patients in Japan were measured by the antibody capture ELISA and applied to distinguish JE virus infection from dengue virus infection. Titer distribution and the ratio of the titers against JE and dengue antigens led to the following diagnostic criteria. The specimens can be considered as positive with JE when IgM-ELISA titer showed over 200 against JE and 4-fold or more higher than titers against any types of dengue antigens. The specimens can be considered as positive with dengue infection when IgM ELISA titer showed over 200 against one of the 4 types of dengue antigens and 4-fold or more higher than against JE antigen. Based on these criteria, 41 of 42 patients in Japan and 11 of 19 encephalitis patients in Thailand could be diagnosed as having JE virus infection while 2 of 19 encephalitis patients in Thailand and 26 of 44 DHF patients in Thailand could be diagnosed as having dengue virus infections.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989309     DOI: 10.1016/0166-0934(85)90120-x

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  44 in total

1.  Japanese encephalitis.

Authors:  T Solomon; N M Dung; R Kneen; M Gainsborough; D W Vaughn; V T Khanh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154

2.  Comparison of two rapid diagnostic assays for detection of immunoglobulin M antibodies to dengue virus.

Authors:  S J Wu; H Paxton; B Hanson; C G Kung; T B Chen; C Rossi; D W Vaughn; G S Murphy; C G Hayes
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

3.  Use of recombinant envelope proteins for serological diagnosis of Dengue virus infection in an immunochromatographic assay.

Authors:  A J Cuzzubbo; T P Endy; A Nisalak; S Kalayanarooj; D W Vaughn; S A Ogata; D E Clements; P L Devine
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

4.  Serotype-cross-reactive immunoglobulin M responses in dengue virus infections determined by enzyme-linked immunosorbent assay.

Authors:  M Nawa; K I Yamada; T Takasaki; T Akatsuka; I Kurane
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

5.  Serological differentiation of infections with dengue virus serotypes 1 to 4 by using recombinant antigens.

Authors:  Diana Ludolfs; Stefan Schilling; Jan Altenschmidt; Herbert Schmitz
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

6.  Evaluation of a dipstick enzyme-linked immunosorbent assay for detection of antibodies to dengue virus.

Authors:  S J Wu; B Hanson; H Paxton; A Nisalak; D W Vaughn; C Rossi; E A Henchal; K R Porter; D M Watts; C G Hayes
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

Review 7.  Current advances in dengue diagnosis.

Authors:  Pei-Yun Shu; Jyh-Hsiung Huang
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

8.  Concurrent dengue virus and Japanese encephalitis virus infection of the brain: is it co-infection or co-detection?

Authors:  R K Garg; H S Malhotra; A Gupta; N Kumar; A Jain
Journal:  Infection       Date:  2012-06-14       Impact factor: 3.553

9.  Discrimination between primary and secondary dengue virus infection by an immunoglobulin G avidity test using a single acute-phase serum sample.

Authors:  Séverine Matheus; Xavier Deparis; Bhety Labeau; Josiane Lelarge; Jacques Morvan; Philippe Dussart
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

10.  Specific IgM and IgG responses in primary and secondary dengue virus infections determined by enzyme-linked immunosorbent assay.

Authors:  A Sa-Ngasang; S Anantapreecha; A A-Nuegoonpipat; S Chanama; S Wibulwattanakij; K Pattanakul; P Sawanpanyalert; I Kurane
Journal:  Epidemiol Infect       Date:  2005-12-22       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.